P-12, r. 6 - Regulation respecting the medications that a podiatrist who obtained a permit to practise before 1976 may administer or prescribe

Updated to 1 September 2012

This document has official status.

chapter P-12, r. 6

Regulation respecting the medications that a podiatrist may use in the practice of his profession or administer or prescribe to his patients

Podiatry Act

(chapter P-12, s. 12).

1. A podiatrist entered on the roll of the Ordre des podiatres du Québec may use in the practice of his profession or administer or prescribe to his patients the medications listed in Schedule I or in Schedule II, subject to the conditions prescribed in this Regulation.

A podiatrist who administers or prescribes to patients the medications listed in Schedule II that are not medications listed in Schedule I must hold a certificate issued by the Ordre des podiatres du Québec acknowledging that the podiatrist received university training in podiatric medicine in the last 5 years, comprising a minimum of 1145 hours apportioned as follows:

(1)  540 hours in anatomy-physiology;

(2)  90 hours in biochemistry;

(3)  105 hours in microbiology;

(4)  275 hours in general pathologies;

(5)  90 hours in basic pharmacology; and

(6)  45 hours in clinical pharmacology.

A podiatrist whose training referred to in subparagraphs 1 to 6 of the second paragraph was received more than 5 years previously must successfully complete the continuing education activities determined by the Ordre des podiatres du Québec pursuant to paragraph o of section 94 of the Professional Code (chapter C-26) and hold a certificate issued by the Order acknowledging that the activities were successfully completed, before the medications listed in Schedule II that are not medications listed in Schedule I may be administered to patients.

O.C. 1057-91, s. 1; O.C. 142-2003, s. 1.

2. (Revoked).

O.C. 1057-91, s. 2; O.C. 142-2003, s. 2.

3. (Omitted).

O.C. 1057-91, s. 3.

SCHEDULE I

NOTE : Medications without specification are intended for topical application.

________________________________________________________________

Substances                    Specification
________________________________________________________________

Acetaminophen                 Pharmaceutical forms intended 
                              for oral and rectal
                              administration

Acetic, glacial acid

Acetylsalicylic,              Pharmaceutical forms intended 
                              for oral administration

Aluminium and its salts

Almond, sweet oil

Amino acids

Amcinonide                    Quantity limited for 30 days

Anthralin (dithranol)

Silver nitrate
 
Silver sulfadiazine

Colloidal oatmeal

Bacitracin and its salts

Beclomethasone and its salts

Benzalkonium

Benzocaine

Betamethasone benzoate

Betamethasone                 Quantity limited for 30 days
dipropionate

Betamethasone valerate

Bupivacaine and               Pharmaceutical forms intended
its salts                     for administration by injection 
                              for local use only

Calcipotriol

Calcium acetate

Camphor

Cantharin

Capsaicin

Cetrimide

Cetirizine                    Pharmaceutical form intended 
hydrochloride                 for oral administration

Chlorhexidine and its salts

Chlorphenesin

Chlorprocaine                 Pharmaceutical form intended 
hydrochloride                 for administration by injection  
                              for local use only

Ciclopirox olamine

Cinchocaine

Clioquinol 
(iodochlorhydroxyquin)

Clobetasol                    Quantity limited for 30 days
proprionate 

Clobetasone butyrate

Clotrimazole

Collagenase

Dakin’s solution

Desonide

Desoximetasone                Quantity limited for 30 days

Deoxyribonuclease

Dichloracetic acid

Diflucortolone                Quantity limited for 30 days
valerate

Diphenhydramine               Pharmaceutical forms intended 
                              for oral and topical
                              administration

Econazole nitrate

Epinephrine                   Pharmaceutical forms for the 
(adrenaline)                  emergency treatment of 
                              anaphylactic reactions in 
                              the form of self-injector or 
                              vial

                              Pharmaceutical form associated 
                              with local anaesthetics

Erythromycin

Ethyl chloride

Fibrinolysin

Flumetasone pivalate

Fluocinolone                  Quantity limited for 30 days
acetonide

Fluocinode                    Quantity limited for 30 days

Formalin

Framycetin sulfate

Fusidic acid

Gentamicin sulfate

Gentian, violet

Mineral and vegetal tar

Gramicidin

Halcinodide                   Quantity limited for 30 days

Hexachlorophene

Mineral oil

Hydrocortisone and its salts

Hydroxyzine                   Pharmaceutical form intended 
hydrochloride                 for oral administration

Povidone iodine

Iodine tincture

Isopropyl myristate

Ketoconazole

Lactic acid

Lanolin

Lidocaine and                 Pharmaceutical forms intended 
its salts                     for topical application and 
                              administration by injection 
                              for local use only

Loratadine                    Pharmaceutical form intended 
                              for oral administration

Lorazepam                     Pharmaceutical form intended 
                              for oral and sublingual 
                              administration in anticipation 
                              of surgical procedures, 
                              containing 0.5 mg or 1 mg 
                              of Lorazepam per tablet 

                              Quantity limited to 4 tablets

Mafenide and its salts

Menthol

Mepivacaine                   Pharmaceutical form intended 
                              for administration by injection 
                              for local use only

Methylpolysiloxanes

Methylprednisolone acetate

Miconazole nitrate

Mometasone furorate

Mupirocin

Neomycin sulfate

Nystatin

Oxiconazole

Phenol

Podophyllin

Polymyxin B sulfate

Pramoxine

Prilocaine                    Pharmaceutical forms intended 
                              for topical application and 
                              administration by injection 
                              for local use only

Procaine                      Pharmaceutical form intended 
                              for administration by injection 
                              for local use only

Resorcinol and its salts

Diethylamine salicylate

Magnesium salicylate

Methyl salicylate

Triethanolamine salicylate

Salicylic acid

Synthetic sebum

Silicone

Sodium thiosulfate

Sulphur, colloidal, 
precipitate or sublimate

Tazarotene

Terbinafine

Tetracaine and                Pharmaceutical forms intended 
its salts                     for topical application and 
                              administration by injection 
                              for local use only

Tioconazole

Tolnaftate

Triamcinolone                 Quantity limited for 30 days
acetonide

Trichloroacetic acid

Urea                          Pharmaceutical form intended 
                              for topical application, with 
                              a concentration of 30% or less

White petroleum jelly

Zinc oxide

O.C. 1057-91, Sch. I; O.C. 142-2003, s. 3; O.C. 522-2005, s. 1.

SCHEDULE II

NOTE : Medications without specification are intended for topical application.

________________________________________________________________

Substances                    Specification
________________________________________________________________

Acetaminophen                 Pharmaceutical form intended
                              for oral and rectal administration

Acetaminophen and             Pharmaceutical form intended 
codeine                       for oral administration
(in combination)              containing 30 mg or less of 
                              codeine per tablet

Acetic,                       Quantity limited to 24 tablets/
glacial acid                  72 hours

Acetylsalicyclic              Pharmaceutical form intended 
acid                          for oral administration

Aluminium and its salts

Almond, sweet oil

Amcinonide                    Quantity limited for 30 days

Amino acids

Anthralin (dithranol)

Silver nitrate

Silver sulfadiazine

Colloidal oatmeal

Bacitracin and its salts

Beclomethasone and its salts

Benzalkonium

Benzocaine

Betamethasone                 Pharmaceutical forms 
acetate and                   intended for administration by
phosphate                     intramuscular or intradermal 
                              injection 

Betamethasone benzoate

Betamethasone                 Quantity limited for 30 days
dipropionate

Betamethasone valerate

Bleomycin sulfate             Pharmaceutical form injectable in 
                              the plantar lesion without 
                              exceeding 0.8 units up to a maximum
                              of 5 units per treatment

Bupivacaine and               Pharmaceutical form intended for
its salts                     administration by injection for 
                              local use only

Calcipotriol

Calcium acetate

Camphor

Cantharin

Capsaicin

Celecoxib                     Pharmaceutical form intended for
                              oral administration

                              Quantity limited for 30 days

Cetirizine                    Pharmaceutical form intended for
hydrochloride                 oral administration

Cetrimid

Chlorhexidine and its salts

Chlorphenesin

Chlorprocaine                 Pharmaceutical form intended for
hydrochloride                 administration by injection for 
                              local use only

Ciclopirox olamine

Cinchocaine

Clioquinor 
(iodochlorhydroxyquin)

Clobetasol                    Quantity limited for 30 days
proprionate

Clobetasone butyrate

Clotrimazole

Collagenase

Dakin’s solution

Desonide

Desoximetasone                Quantity limited for 30 days

Deoxyribonuclease

Dichloracetic acid

Diclofenac,                   Pharmaceutical form intended 
potassic and sodic            for oral administration

                              Quantity limited for 30 days

Diflucortolone                Quantity limited for 30 days
valerate

Dyphenhydramine               Pharmaceutical forms intended
                              for oral administration and 
                              administration by intramuscular, 
                              subcutaneous or intradermal 
                              injection

Econazole nitrate

Epinephrine                   Pharmaceutical forms for the 
(adrenaline)                  emergency treatment of 
                              anaphylactic reactions in the 
                              form of auto-injector or vial

                              Pharmaceutical form associated 
                              with local anaesthetics

Erythromycin

Ethyl chloride

Fibrinolysin

Flumetasone pivalate

Fluocinolone                  Quantity limited for 30 days
acetonide

Fluocinode                    Quantity limited for 30 days

5-fluorouracil                0.1% pharmaceutical form intended 
                              for topical application in the 
                              case of plantar warts resistant to
                              first-line treatments

Formaline

Framycetin sulfate

Fusidic acid

Gentamicin sulfate

Gentian, violet

Mineral and vegetal tar

Gramicidin

Halcinodide                   Quantity limited for 30 days

Hexachlorophene

Mineral oil

Hydrocortisone and its salts

Hydroxyzine                   Pharmaceutical form intended for 
hydrochloride                 oral administration

Ibuprofen                     Pharmaceutical form intended for 
                              oral administration

                              Quantity limited for 30 days

Povidone iodine

Iodine tincture

Isopropyl myristate

Ketoconazole

Lactic acid

Lanolin

Lidocaine and                 Pharmaceutical forms intended for
its salts                     topical application and 
                              administration by injection for
                              local use only

Loratadine                    Pharmaceutical form intended for
                              oral administration

Lorazepam                     Pharmaceutical form intended for 
                              oral and sublingual administration
                              in anticipation of surgical 
                              procedures, containing 0.5 mg or 
                              1 mg of Lorazepam per tablet

                              Quantity limited to 4 tablets

Mafenide and its salts

Menthol

Mepivacaine                   Pharmaceutical form intended for
                              administration by injection 
                              for local use only

Methylpolysiloxanes

Methylprednisolone            Pharmaceutical forms intended for
acetate                       topical application and 
                              administration by injection for 
                              local use only
Miconazole nitrate

Mometasone furorate

Mupirocin

Naproxen                      Pharmaceutical form intended for 
                              oral administration

                              Quantity limited for 30 days

Neomycin sulfate

Nystatin

Oxiconazole

Phenol

Podophyllin

Polymyxin B sulfate

Pramoxine

Prilocaine                    Pharmaceutical forms intended for
                              topical application and 
                              administration by injection for 
                              local use only

Procaine                      Pharmaceutical form intended for
                              administration by injection for
                              local use only

Resorcinol and its salts

Rofecoxib                     Pharmaceutical form intended for
                              oral administration
                              Quantity limited for 30 days

Diethylamine salicylate

Magnesium salicylate

Methyl salicylate

Triethanolamine salicylate

Salicylic acid

Synthetic sebum

Silicone

Sodium thiosulfate

Sulphur, colloidal,
precipitate or sublimate

Tazarotene

Terbinafine

Tetracaine and                Pharmaceutical forms intended for
its salts                     topical application and 
                              administration by injection for
                              local use only
Tioconazole

Tolnaftate

Triamcinolone                 Quantity limited for 30 days
acetonide

Triamcinolone                 Pharmaceutical forms intended for
hexacetonide                  administration by intramuscular or
                              intradermal injection
                              Quantity limited for 30 days

Trichloroacetic acid

Urea                          Pharmaceutical form intended for 
                              topical application, with a 
                              concentration of 30% or less

White petroleum jelly

Zinc oxide

O.C. 142-2003, s. 3; O.C. 522-2005, s. 2.

REFERENCES

O.C. 1057-91, 1991 G.O. 2, 3231

O.C. 142-2003, 2003 G.O. 2, 1013

O.C. 522-2005, 2005 G.O. 2, 1872